Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Simon Christopher Robson, Ph.D., M.B.Ch.B.

Co-Author

This page shows the publications co-authored by Simon Robson and Francisco Quintana.
Connection Strength

1.339
  1. Author Correction: Control of tumor-associated macrophages and T cells in glioblastoma via AHR and CD39. Nat Neurosci. 2019 Sep; 22(9):1533.
    View in: PubMed
    Score: 0.216
  2. Control of tumor-associated macrophages and T cells in glioblastoma via AHR and CD39. Nat Neurosci. 2019 05; 22(5):729-740.
    View in: PubMed
    Score: 0.210
  3. Bilirubin suppresses Th17 immunity in colitis by upregulating CD39. JCI Insight. 2017 May 04; 2(9).
    View in: PubMed
    Score: 0.184
  4. Regulation of the T Cell Response by CD39. Trends Immunol. 2016 07; 37(7):427-439.
    View in: PubMed
    Score: 0.172
  5. Metabolic control of type 1 regulatory T cell differentiation by AHR and HIF1-a. Nat Med. 2015 Jun; 21(6):638-46.
    View in: PubMed
    Score: 0.160
  6. Characterization of human CD39+ Th17 cells with suppressor activity and modulation in inflammatory bowel disease. PLoS One. 2014; 9(2):e87956.
    View in: PubMed
    Score: 0.147
  7. IL-27 acts on DCs to suppress the T cell response and autoimmunity by inducing expression of the immunoregulatory molecule CD39. Nat Immunol. 2013 Oct; 14(10):1054-63.
    View in: PubMed
    Score: 0.142
  8. Negative feedback control of neuronal activity by microglia. Nature. 2020 10; 586(7829):417-423.
    View in: PubMed
    Score: 0.058
  9. HIF-1a-induced xenobiotic transporters promote Th17 responses in Crohn's disease. J Autoimmun. 2018 11; 94:122-133.
    View in: PubMed
    Score: 0.050
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.